Tags
- 06
- 2B
- 3
- A
- Acro
- Across
- Advanced
- Advancement
- Advances
- Advancing
- Affiliate
- AIM
- Aims
- Allosteric regulation
- Ally Bridge
- An
- Analytic
- Analytics
- Anticipation
- Application
- Approximately
- Asia
- Asset
- Asset management
- Assets under management
- Autoimmune
- Autoimmune disease
- Bay
- Bay Area
- Being
- Best-in-class
- Big data
- Biology
- Biopharmaceutical
- Biotechnology
- Board of directors
- Breed
- Bridge
- Broad
- Calif
- Candidate
- Capital
- Capital I
- Capital management
- CEO
- Chief
- Chief executive
- Chief executive officer
- Clinical
- Clinical program
- Clinical trial
- Clinical Trials
- Collaboration
- Combined
- Commitment
- Communication
- Comprehensive
- Contact
- Continued
- Cormorant
- Cross-platform
- Cutting Edge
- Cycles
- Dahlman
- Data
- Data analysis
- Data science
- Demonstration
- Development
- Discovery!
- Discovery and development
- Disease
- Drive
- Drug
- Drug development
- Drug discovery
- Dysfunction
- Efficacy
- Endowment
- Enter
- Entrepreneur
- Entrepreneurship
- Executive
- Executive officer
- Existence
- Explore
- Family Office
- Field
- Focus
- Foundation
- Foundations
- Founder
- Founding
- Francisco Bay
- Fund
- Gaster
- General partner
- Generation
- Genetic
- Genetics
- Globe
- GlobeNewswire
- Goal
- Grateful
- Growth
- Hands On
- Happy
- Harness
- HBM
- Health care
- Heartland
- Identified
- Immune
- Immune disorder
- Immunology
- Improved
- Include
- Includes
- Incubation
- Indication
- Industry leaders
- Information Please
- Inhibition
- Inhibitor
- Initiate
- Innovation
- Insight
- Insights
- Instrument approach
- Invest
- Investment
- Investment company
- Investor
- Kinase
- Lab
- Labs
- Leader
- Leverage
- Life Cycles
- Life science
- Life Sciences
- Lilly Asia
- Long term
- Los Angele
- Los Angeles
- Lumus
- Lupus
- Lupus erythematosus
- Manage
- Martin Babler
- Matrix
- M.D.
- MD–PhD
- Medical
- Medicine
- Moderate
- Multistage rocket
- Need
- Needs
- Neurodegeneration
- New
- New Breed
- News agency
- New York
- New York City
- Nex Entertainment
- Next
- Next Generation
- Novel
- Officer
- Open-label trial
- Optimize
- Paradigm
- Participation
- Partner
- Partners
- Partnership
- Pathway
- Patient
- Pharmaceutical drug
- Phase
- Phase 1
- PHASE 2
- Phase 3
- PHD
- Pipeline
- Pivotal
- Plaque
- Platform
- Powerful
- Precision
- Private Life
- Proceed
- Profile
- Programmer
- Promising
- Proof of concept
- Proof-of-concept phase
- Proprietary
- Proud
- Proven
- Psoriasis
- Record
- Red House
- Remake
- Richard Gaster
- Robustness
- Safety
- Samsara
- San Francisco
- San Francisco Bay
- San Francisco Bay Area
- Science
- Scientific
- Scientist
- Second
- Second Half
- Selective
- Serie A
- Severity
- Shares
- SLE
- South San Francisco, California
- Stride
- Strong
- Success
- Sustain
- Syndicate
- Synergy
- Systemic
- Systemic lupus erythematosus
- Target
- Targets
- Team a
- Technology
- Teri Dahlman
- The Broad
- The Colourist
- The discovery
- The firm
- The first
- Therapy
- Today
- Track Record
- Track Records
- Transform
- Transformation
- Transforming
- Translate
- Translation
- Treat
- Trial
- Trials
- Tyrosine
- Tyrosine kinase
- Tyrosine kinase 2
- Undisclosed Desires
- Uses
- Uveitis
- Validated
- Value proposition
- Venture round
- Visit